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SLX4, a scaffold for structure-specific DNA repair
nucleases, is important for several types of DNA
repair. Many repair proteins bind to sites of DNA
damage, resulting in subnuclear ‘‘foci,’’ but SLX4
forms foci in human cells even without DNA damage.
Using several approaches, we show that most, but
not all, SLX4 foci localize to telomeres in a range of
human cell lines irrespective of the mechanisms
used to maintain telomere length. The SLX1 Holli-
day-junction-processing enzyme is recruited to
telomeres by SLX4, and SLX4, in turn, is recruited
by a motif that binds to the shelterin subunit TRF2
directly. We also show that TRF2-dependent recruit-
ment of SLX4 prevents telomere damage. Further-
more, SLX4 prevents telomere lengthening and
fragility in a manner that appears to be independent
of telomere association. These findings reveal that
SLX4 plays multiple roles in regulating telomere
homeostasis.INTRODUCTION
SLX4 is a scaffold protein that binds to three DNA repair endo-
nucleases, MUS81-EME1, XPF-ERCC1, and SLX1 (Andersen
et al., 2009; Fekairi et al., 2009; Mun˜oz et al., 2009; Saito et al.,
2009; Svendsen et al., 2009). The SLX4 complex is required for
the efficient repair of DNA interstrand crosslinks (ICLs), (Fekairi
et al., 2009; Mun˜oz et al., 2009; Svendsen et al., 2009), and the
available evidence strongly suggests a role in processing DNA
recombination intermediates during ICL repair. The importance
of SLX4 for ICL repair was underscored by the findings that bial-
lelic mutations in SLX4 in humans causes Fanconi anemia (FA)
(Kim et al., 2011; Stoepker et al., 2011).
Many DNA repair proteins form subnuclear ‘‘foci’’ at sites of
DNA damage, but SLX4 overexpressed in epitope-tagged form
localizes to subnuclear foci even without DNA damage (Svend-
sen et al., 2009). It was suggested that these foci correspond
to telomeres, regions of repetitive DNA at chromosome ends,
which protect the ends from degradation (Svendsen et al.,Cel2009). Telomeres terminate in an overhang that is thought to
invade adjacent duplex telomeric repeats to form a telomeric
(T) loop so that the chromosome ends are not perceived as
DNA breaks. An additional layer of telomere protection is af-
forded by a multiprotein complex called shelterin, that binds to
telomeric DNA (Palm and de Lange, 2008). In normal somatic
cells, telomeres shorten with every cell division, and telomere
shortening contributes to organismal aging by limiting the prolif-
erative capacity of adult stem cells (Blasco, 2007). In immortal-
ized cells and in cancers, telomere length is maintained by telo-
merase, a reverse transcriptase that can add telomere repeats
with the aid of an associated RNA template (Greider and Black-
burn, 1989; Mocellin et al., 2013). Some other immortalized cells,
cancer cells, and even normal somatic cells can lengthen telo-
meres in a telomerase-independent manner using the ALT (alter-
native lengthening of telomeres) pathway, which probably in-
volves recombination (Bryan et al., 1995; Cesare and Reddel,
2010; Neumann et al., 2013).
A number of observations suggest that SLX4 might function at
telomeres. First, when overexpressed in a special clone of HeLa
cells with abnormally long telomeres SLX4 forms subnuclear foci
that colocalize with shelterin (Svendsen et al., 2009). Second,
SLX4 was identified in a global screen for proteins that bind
telomeres (De´jardin and Kingston, 2009). Third, SLX4 interacts
with TRF2 and RAP1 (Mun˜oz et al., 2009; Svendsen et al.,
2009), which are subunits of shelterin. Also, SLX4 promotes telo-
mere cleavage in cells lacking the RTEL1 helicase (Vannier et al.,
2012). In Rtel1/ cells, replisomes stall in telomeres leading to
cleavage of T loops and the production of extrachromosomal T
circles, which is mediated by the SLX4 complex (Vannier et al.,
2012). Although these observations link the SLX4 complex to
telomeres, it is not known whether endogenous SLX4 localizes
at telomeres, if this is applicable in cells that differ in the mecha-
nisms used tomaintain telomere length, or how SLX4 is recruited
to chromosome ends. Furthermore, in RTEL1-proficient cells it
remains to be determined if SLX4 has a physiological role to
play in telomere homeostasis. Here, we address these issues.
RESULTS
The Endogenous SLX4 Complex Localizes at Telomeres
We first tested if endogenous SLX4 localizes at telomeres. Using
antibodies raised in-house, we found that endogenous SLX4l Reports 4, 853–860, September 12, 2013 ª2013 The Authors 853
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Figure 1. Endogenous SLX4 Complex Localizes at Telomeres in
U2OS cells
(A) Indirect immunofluorescence analysis of SLX4 and TRF2 in U2OS cells.
Cells were fixed and preextracted, and SLX4 or TRF2 foci were visualized.
(B) U2OS cells were fixed and SLX4 or TRF1 foci were visualized by indirect
immunofluorescence. Cells were then fixed again and subjected to FISH
analysis with a telomeric PNA probe.
(C) Same as (A), except that a straight line was drawn using OMERO Insight
(Allan et al., 2012) through a single Z-section of the nucleus, and the intensity of
the SLX4, TRF2, or DAPI signals was quantitated along the length of the line.
a.u.f., arbitrary units of fluorescence.
(D) U2OS cells stably expressing GFP-SLX4 or an SLX4 mutant incapable of
interacting with SLX1 (GFP-SLX4-C1805R) were fixed, and GFP-SLX4 or SLX1
foci were visualized by indirect immunofluorescence.
(E) Indirect immunofluorescence analysis of SLX1 and TRF2 in U2OS cells
stably overexpressing GFP-tagged SLX1.
See also Figure S1.forms subnuclear foci in U2OS cells without addition of genotox-
ins (Figure 1A). These foci are specific for SLX4 because they
disappeared when cells were transfected with SLX4-specific
small interfering RNAs (siRNAs) (Figure S1A). Endogenous854 Cell Reports 4, 853–860, September 12, 2013 ª2013 The AuthorSLX4 foci did not appear to be restricted to any particular cell-
cycle stage, and they did not increase in number or intensity after
exposure of cells to genotoxins (data not shown). To investigate
if endogenous SLX4 foci correspond to telomeres, we tested
colocalization with subunits of shelterin. Most (around 80%),
but not all, endogenous SLX4 foci colocalized with TRF2 in
U2OS cells (Figure 1A), and also with TRF1 and with a peptide-
nucleic acid (PNA) probe specific for telomeric DNA (Figure 1B).
When signal intensity was measured along a straight line in a
single Z-section through the nucleus, the peaks corresponding
to SLX4 overlap with TRF2 (Figure 1C). It is important to note
that, whereas all TRF2 foci in U2OS cells contained SLX4, a
proportion of SLX4 foci did not overlap with TRF2 (Figure 1A).
These observations indicate that SLX4 is found at all telomeres
in U2OS cells, but a proportion of the SLX4 foci do not corre-
spond to telomeres.
SLX4 associates with three separate structure-specific nucle-
ases , XPF-ERCC1, MUS81-EME1, and SLX1. XPF-ERCC1 was
previously shown to localize at telomeres (Zhu et al., 2003), and
in this light we found that all of the XPF-ERCC1 foci in cells
colocalize with SLX4 (Figures S1B and S1D). MUS81-EME1
was also shown to localize at telomeres (Zeng et al., 2009),
but only around 5%of U2OS cells showMUS81 foci colocalizing
with SLX4 (Figures S1C and S1D). Endogenous SLX1 foci were
only barely detectable with our anti-SLX1 antibodies (data not
shown). SLX4 controls the stability of SLX1 (Mun˜oz et al.,
2009), and overexpression of a GFP-tagged form of SLX4
increased the levels of endogenous SLX1 (data not shown). Un-
der these conditions, endogenous SLX1 foci could be detected
with anti-SLX1 antibodies (Figure 1D), and most of these foci
colocalize with TRF2 (data not shown). In contrast, SLX1 foci
could not be detected when we overexpressed a mutant form
of SLX4 (C1805R) that is incapable of interacting with SLX1
(Figure 1D) (D.C., N. Nair, A.C. Declais, C. Lachaud, R.T., T.J.
Macartney, D.M.J. Lilley, J.S.C. Arthur, and J.R., unpublished
data). We also found that a GFP-tagged form of SLX1 formed
foci that colocalized with TRF2 (Figure 1E). Taken together,
these data show that the endogenous SLX4 complex localizes
at telomeres.
SLX4 Binds to Telomeres in Cells Differing in
Mechanisms of Telomere Length Maintenance
To confirm the association of SLX4 with telomeres, we carried
out chromatin immunoprecipitation (ChIP) experiments. Telo-
meric DNA, but not Alu repeat DNA, was detected in SLX4
immunoprecipitates of U2OS cells using two separate anti-
SLX4 antibodies raised in sheep, but not when nonspecific
sheep immunoglobulin (Ig) G or anti-CENPA antibodies were
used. The ChIP signal in SLX4 precipitates was comparable to
the signal in TRF2 precipitates (Figure 2A). We also detected
telomeric DNA, but not Alu DNA, in anti-SLX1 immunoprecipi-
tates in U2OS cells (Figure 2B).
Telomere length is maintained by the ALT pathway in U2OS
cells, whereas in other cell lines telomere length can be main-
tained by telomerase (Cesare and Reddel, 2010). ChIP experi-
ments showed that SLX4 associates with telomeric DNA, but
not Alu DNA, in A549 and HeLa epithelial cells, two non-ALT
cell lines that are telomerase positive (Figures 2C and 2D, lefts
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Figure 2. Multiple Approaches Detect SLX4
at Telomeres in Several Human Cell Lines
(A and B) U2OS cells were fixed with formalde-
hyde, and ChIP analysis was performed with the
antibodies indicated. DNA from immunoprecipi-
tates was subjected to 3-fold serial dilutions
before spotting onto Hybond N+ and subjected to
hybridization with a radioactively labeled telomeric
probe or an Alu DNA probe. Input DNA prepared
from cell extracts before immunoprecipitation was
subjected to similar analysis.
(C) ChIP analysis (left panels) and indirect immu-
nofluorescence analysis of SLX4 or TRF2 foci
(middle and right panels) in A549 cells. In the
middle panel, a straight line was drawn through a
single Z-section of the nucleus, and the intensity of
the SLX4, TRF2, or DAPI signals was quantitated
along the length of the line (right panel).
(D) Same as (C) except that HeLa cells were used.
a.u.f., arbitrary units of fluorescence. In all ChIP
experiments, the ‘‘input DNA’’ lane shows 10%,
3%, and 1% of the total DNA in cell extract,
respectively.
See also Figure S2.panels). The ChIP signal in anti-SLX4 immunoprecipitates from
these cells was weaker than in U2OS cells, probably because
A549 and HeLa cell telomeres are shorter than in U2OS cells
(Lee et al., 2008). Nonetheless, the ChIP signal in SLX4 precip-
itates from A549 and HeLa cells was comparable to the signal in
TRF2 precipitates (Figures 2C and 2D, left panels). Furthermore,
SLX4 foci in A549 cells and HeLa cells are considerably less
intense than in U2OS cells, but a significant proportion of the
foci still colocalized with TRF2 (Figures 2C and 2D, middle
panels). When signal intensity along an arbitrary track in a single
Z-section of the nucleus was quantitated, the peaks corre-
sponding to SLX4 and TRF2 in A549 and HeLa cells demon-
strated good overlap (Figures 2C and 2D, right panels). We
also observed SLX4 foci in CCL-211 primary lung fibroblasts,
and some of these colocalize with TRF1 similar to HeLa cells
(Figure S1E). Although a significant proportion of telomeric
foci in these cells do not contain SLX4, when signal intensity
along an arbitrary track in a single Z-section of the nucleus
was quantitated, the peaks corresponding to SLX4 demon-Cell Reports 4, 853–860, Sestrated reasonably good overlap with
TRF1 (Figure S1E). Taken together, these
data show that the SLX4 complex local-
izes at telomeres in a range of human
cell lines that differ in the mechanisms
used to maintain telomere length.
SLX4 Has a TRF2-Binding Motif
Both subunits of the TRF2-RAP1 shelterin
subcomplex were found previously in
SLX4 immunoprecipitates (Mun˜oz et al.,
2009; Svendsen et al., 2009). We next
sought to determine whether SLX4 is
recruited to telomeres by either of these
two proteins. Yeast two-hybrid analysis,using XPF as a positive control, revealed that SLX4 binds to
TRF2, not RAP1 (Figure 3A), and it seemed likely therefore that
SLX4 is recruited to telomeres by TRF2. To investigate this pos-
sibility, we sought mutations in SLX4 that abolish the interaction
with TRF2, and our search was aided by a previous report
describing a motif found in a range of proteins that interact
with TRF2 (F/Y-X-L-X-P; Figure 3B) (Chen et al., 2008). Inspec-
tion of the primary amino acid sequence of human SLX4 failed
to identify a classical TRF2-binding motif (TBM), but we found
a TBM-likemotif (H1020-X-L1022-X-P1024) in which the first residue
(F/Y) is replaced by a histidine residue, which like F and Y con-
tains a planar aromatic ring structure (Figure 3B). This motif in
SLX4 lies after the BTB domain in an unstructured region of
the protein (Figure 3B, data not shown).
We next tested the effect of mutating the key residues in the
putative TBM in human SLX4 on its interaction with TRF2. To
this end, U2OS cells were cotransfected with RFP-tagged
TRF2 and HA-tagged SLX4 wild-type or HA-SLX4 in which
H1020, L1022, or P1024 were mutated to alanine. Whereasptember 12, 2013 ª2013 The Authors 855
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Figure 3. A TRF2-Binding Motif in SLX4
(A) Yeast two hybrid analysis was performed with a
GAL4 activation domain (GAD) fusion of SLX4 and
GAL4 DNA binding domain (GBD) fusion of TRF2,
RAP1, or XPF to detect interaction between these
proteins. Cells grown on medium lacking LEU and
TRP (to select for bait and prey plasmids) were
replica plated to medium lacking LEU, TRP, and
HIS to test for activation of the HIS3 reporter gene.
(B) Schematic diagram of the modular domain
organization of SLX4. The putative TBM is high-
lighted in red, and the sequence of the putative
TBM from SLX4 is compared with the classical
TRF2-binding motif (TBM).
(C) U2OS cells were cotransfected with RFP-tag-
ged TRF2 and HA-tagged SLX4 wild-type (WT), or
HA-SLX4 bearing alanine substitutions at H1020,
L1022, or P1024. Vector expressing HA tag only
was used as control. Cells were lysed and sub-
jected to immunoprecipitation with anti-RFP anti-
bodies, and precipitates were probed with the
antibodies indicated.
(D) Same as (C) except that SLX4wasGFP tagged,
and extracts were subjected to immunoprecipita-
tion with anti-GFP antibodies.
(E) Indirect immunofluorescence analysis of U2OS
cells stably expressing GFP-SLX4-L1022A. GFP-
SLX4 or endogenous TRF2 foci were visualized.
(F) The proportion of foci in U2OS cells formed by
GFP-SLX4 or GFP-SLX4-L1022A that cocoloc-
alize with TRF2, that are adjacent to but not
overlapping with TRF2, or that do not colocalize
with TRF2 was quantitated.
(G) Telomere-ChIP analysis of GFP-SLX4 or GFP-
SLX4-L1022A, or GFP only, stably expressed in
U2OS cells. DNA from immunoprecipitates was
subjected to 3-fold serial dilutions, before spotting
onto Hybond N+ and hybridization with a radio-
actively labeled telomeric probe (upper panel) or
an Alu DNA probe (lower panel). Input DNA pre-
pared from cell extracts before immunoprecipita-
tion was subjected to similar analysis. The ‘‘input
DNA’’ lane shows 10%, 3%, and 1% of the total
DNA in cell extract, respectively.
(H) The ChIP signal in the dots corresponding to
each serial dilution for each immunoprecipitate in
(G) was quantitated and added together. To
normalize the hybridization signals, the resulting
totals for each precipitate were divided by the total
input signal (left panels).
See also Figures S2 and S3.wild-type HA-SLX4 coprecipitated with RFP-TRF2, mutation of
H1020, L1022, or P1024 caused amajor reduction in the amount
of HA-SLX4 coprecipitating with RFP-TRF2 (Figure 3C). Similar
results were obtained when GFP-tagged SLX4 was immunopre-
cipitated from cells coexpressing RFP-TRF2 (Figure 3D). Impor-
tantly, mutating H1020, L1022, or P1024 had no effect on the
ability of SLX4 to interact with XPF-ERCC1, MUS81, or SLX1
(Figure S2A). Taken together, these data show that a TBM in
human SLX4mediates interaction with TRF2. Intriguingly, a clear
TBM is found in SLX4 in primates but not in mammals lower
down the evolutionary tree (Figure S2B). SLX4 orthologs in
some mammals have a motif that is vaguely similar to the TBM
in primates (Figure S2B), but none of the mammalian motifs856 Cell Reports 4, 853–860, September 12, 2013 ª2013 The Authorwould be expected to interact with TRF2 based on previous
work (Chen et al., 2008).
The SLX4 Complex Is Recruited to Telomeres by TRF2 in
Human Cells
We next tested if mutating the TBM in SLX4 affects its localiza-
tion at telomeres. To this end, GFP-tagged wild-type SLX4, or
GFP-SLX4-L1022A, was stably expressed in U2OS cells and
foci were analyzed. Surprisingly, the overall number of foci
formed by the SLX4 L1022A mutant was similar to wild-type
SLX4 (Figures 3E and 3F). However, whereas almost 65% of
wild-type GFP-tagged SLX4 foci colocalized with TRF2, only
around 10% of foci formed by the SLX4 L1022A mutants
coincided with TRF2, and more than 40% of the foci clearly did
not (Figures 3E and 3F). The remaining 40%of SLX4–L1022A foci
did not colocalize with TRF2, but were found adjacent to, but
distinct from TRF2 foci (Figures 3E and 3F). To further test the
impact of mutating the SLX4 TBM on telomere binding, we
used ChIP analysis, which revealed that mutating SLX4 L1022
to alanine caused an almost 80% reduction in the amount of te-
lomeric DNA associated with SLX4 (Figures 3G and 3H). These
data suggest that TRF2 is required for localizing SLX4 at telo-
meres. We tested this idea further using a dominant-negative
form of TRF2 (TRF2DBDM) that heterodimerizes with endoge-
nous TRF2 blocking its binding to DNA (van Steensel et al.,
1998). As shown in Figure S2C, overexpression of an RFP-
tagged form of TRF2DBDM, but not wild-type TRF2, caused a
substantial reduction in the number of SLX4 foci in U2OS cells
(Figure S2C). Some of the cells transfected with TRF2DBDM
did not express this protein, and SLX4 foci were normal in these
cells (Figure S2C). Taken together, these data indicate that TRF2
recruits SLX4 to telomeres in human cells.
We also tested if the SLX4-TRF2 interaction is required for
association of SLX1 with telomeres. We showed earlier that
endogenous SLX1 forms TRF2-coincident foci in cells over-
expressing wild-type SLX4 (Figure 1D). SLX1 also forms foci in
cells overexpressing SLX4-L1022A, but, although these foci
colocalize with SLX4-L1022A, they do not colocalize with TRF2
(Figure S3A). This experiment shows that SLX1 is recruited to
telomeres by SLX4.
SLX4 Localizes at and Repairs DNA Damage
Independently of TRF2
SLX4 is required for efficient DNA repair. Because TRF2 has
been shown to localize at sites of DNA damage (Huda et al.,
2012), and to promote DNA repair (Huda et al., 2009), we
tested the possibility that TRF2 might recruit SLX4 to DNA
damage sites as well as to telomeres. To this end, we induced
DNA damage using local laser microirradiation and then
checked by confocal microscopy for the ability of SLX4 to
form ‘‘laser stripes.’’ Time-lapse experiments revealed that
GFP-tagged SLX4 formed subnuclear stripes along the track
of DNA damage induced by laser irradiation visible within
12 min of irradiation, reaching a maximum intensity after 1 hr
(Figure S3B). The SLX4-L1022A mutant localized at tracks of
laser-induced DNA damage with similar kinetics and intensity
to wild-type SLX4 (Figure S3B). We conclude from these data
that TRF2 is not required to localize SLX4 at sites of DNA
damage.
We also tested if the association of SLX4 with TRF2 is required
for DNA repair using genotoxin hypersensitivity as readout. To
this end, we stably expressed untagged forms of SLX4 and
SLX4-L1022A in cells from Fanconi anemia patient EUFA-1354
that express abnormally low levels of an N-terminally truncated
form of SLX4 (Stoepker et al., 2011). Empty vector was used
as control. As shown in Figure S3C, wild-type SLX4 and SLX4-
L1022A are indistinguishable in their ability to rescue the mito-
mycin-C hypersensitivity of EUFA-1354 cells. Taken together,
the data above indicate that neither the localization of SLX4 at
DNA damage sites, nor the ability of SLX4 to promote DNA
repair, requires binding to TRF2.CelLocalization-Dependent and -Independent Roles for
SLX4 in Promoting Telomere Homeostasis
We next tested if preventing localization of SLX4 at telomeres
affects telomere function. Because the L1022A SLX4 mutant
interacts with XPF-ERCC1, MUS81-EME1, and SLX1 (Fig-
ure S2A) but does not localize at telomeres (Figures 3E–3H),
we reasoned that it might function as a dominant negative by
sequestering the associated nucleases away from telomeres.
In this light, we made U2OS cells that stably express GFP-
tagged SLX4, or GFP-SLX4-L1022A in a tetracycline-inducible
manner. Upon induction of SLX4-L1022A, we noticed an in-
crease in the proportion of cells with ‘‘TIFs’’ (telomere dysfunc-
tion-induced foci) (Takai et al., 2003), defined as 53BP1 foci
that colocalize with TRF1, compared with cells expressing
wild-type SLX4 (Figure 4A). In contrast, there was little difference
between wild-type SLX4 and the SLX4-L1022A mutant in terms
of the induction of 53BP1 foci that did not colocalize with TRF1
(Figure 4A). This experiment argues that failure to properly target
SLX4 to telomeres causes telomere damage. Consistent with
these data, siRNA-mediated depletion of SLX4 from U2OS cells
increased the proportion of cells with TIFs (Figures S4A and
S4B). SLX4-specific siRNAs 3 and 4 resulted in more efficient
depletion of SLX4 than siRNAs 1 and 2, and consequently they
were more potent at inducing TIFs.
Intriguingly, the lack of an obvious TRF2 binding motif in
nonprimate mammalian orthologs of SLX4 suggests that SLX4
should not localize at telomeres in mouse cells, for example,
andwe next investigated this possibility. As shown in Figure S4C,
whereas human SLX4 forms foci that colocalize with TRF2 when
ectopically expressed in mouse embryonic fibroblasts (MEFs),
mouse SLX4 forms foci but they do not colocalize with TRF2.
This is reminiscent of the humanSLX4-L1022Amutant that forms
foci that do not colocalize with telomeres (Figure 3E–3H). These
observations indicate that SLX4 does not associate stably with
telomeres in mouse cells, at least in fibroblasts. Nonetheless,
we reasoned that SLX4 might have roles at telomeres that do
not require stable association with chromosome ends. With
this in mind, we analyzed telomeres in Slx4/ mice generated
in this laboratory, which will be described in detail elsewhere
(D.C., N. Nair, A.C. Declais, C. Lachaud, R.T., T.J. Macartney,
D.M.J. Lilley, J.S.C. Arthur, and J.R., unpublished data). Analysis
of organs and cells from these mice revealed a number of telo-
mere defects. First, we observed increased incidence of TIFs
in mouse embryonic fibroblasts (MEFs) from Slx4/ mice (Fig-
ure S4D). Second, telomeres in livers from Slx4/ mice were
longer than in Slx4+/ mice or wild-type mice (Figure 4B). Telo-
meres were also longer in MEFs from Slx4/ mice, but length-
ening was reversed by expression of mouse SLX4 in these cells
so that telomeres were similar in length to wild-type MEFs (Fig-
ure 4C). These data suggest that SLX4 might play a role in trim-
ming telomeres to prevent overlengthening. We also found that
telomeres from Slx4/ MEFs show increased fragility assessed
by the frequency ofmultitelomeric signals (MTSs) comparedwith
Slx4+/ MEFs and wild-type cells (Figure 4D). The data above
indicate that targeting of SLX4 to telomeres prevents DNA dam-
age in human cells, and that SLX4 also plays a role in telomere
homeostasis in mice in a manner that does not appear to require
the stable retention of the SLX4 complex at telomeres.l Reports 4, 853–860, September 12, 2013 ª2013 The Authors 857
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Figure 4. Localization-Dependent and -Independent Roles of SLX4
in Regulating Telomere Homeostasis
(A) U2OS cells stably expressing tetracycline-inducible forms of GFP-SLX4
wild-type (WT) or GFP-SLX4-L1022A were incubated, or not, with tetracycline
for 48 hr to induce maximal protein expression. Cells were fixed and subjected
to immunofluorescence analysis of 53BP1 foci and TRF1 foci. The proportion
of cells with greater than three 53BP1 foci that colocalized with TRF1 (‘‘telo-
meric’’), and that did not colocalize with TRF1 (‘‘nontelomeric’’) was counted
before and after addition of tetracycline. The fold change after addition of
tetracyclinewas calculated. At least 200 cells were counted for each condition,
in two independent experiments.
(B) Telomere fluorescence distribution of individual telomere dots in paraffin-
embedded liver sections of mice of the indicated genotype as determined by
q-FISH analysis. Mean fluorescence is indicated by the red horizontal line;
a.u.f., arbitrary units of fluorescence. The total numbers of mice and nuclei
analyzed per genotype are indicated. The Wilcoxon-Mann-Whitney rank sum
test was used for statistical comparison; p values are indicated.
(C) Telomere fluorescence distribution of individual telomere dots in MEFs
from wild-type mice or Slx4/ mice stably expressing mouse SLX4, as
determined by q-FISH analysis. Empty vector was used as control. Mean
fluorescence is indicated by the red horizontal line; a.u.f., arbitrary units of
fluorescence. The total numbers of metaphase spreads (‘‘meta’’), and telo-
meres (‘‘telo’’) analyzed per genotype are indicated.
(D) Frequency of multitelomeric signals (MTSs) per metaphase in primary
MEFs of the indicated genotypes. Data are presented as mean and SEM.
Representative images ofMTSs are shown. TheWilcoxon-Mann-Whitney rank
sum test was used for statistical comparison; p values are indicated.
See also Figures S3 and S4.
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In this study, we showed SLX4 is recruited to telomeres in
human cells by TRF2. We identified a motif in human SLX4
required for direct interaction with TRF2 that is similar but not
identical to the TRF2-binding motif (TBM; F/Y-X-L-X-P) identi-
fied in proteins such as Apollo (Chen et al., 2008). In the SLX4
motif, however, the F/Y residue is replaced by a histidine resi-
due. This observation extends the consensus TRF2-binding
motif and raises the possibility that other proteins might interact
with TRF2 through TBMs similar to that of SLX4. Although SLX4
is a rapidly evolving protein, it is somewhat surprising that the
SLX4 TBM-like motif is conserved in primates but not in mam-
mals lower down the evolutionary tree (Figure S2B). The
absence of a TBM, however, does not exclude the possibility
that SLX4 (or an SLX4-associated protein) in nonprimate spe-
cies associates with TRF2 and/or telomeres by alternative
mechanisms. However, we have been unable to detect endog-
enous SLX4 at telomeres in mouse embryonic fibroblasts, and,
whereas human SLX4 overexpressed in MEFs forms telomeric
foci, mouse SLX4 does not (Figure S4C). Therefore, SLX4 asso-
ciates with TRF2 and telomeres in primates but not in other
mammals. In human cells, preventing localization of SLX4 at
telomeres caused signs of DNA damage (Figure 4A). The pre-
cise nature of this damage is not yet clear, but it might result
from difficulties in one of the many processing steps during
and after DNA replication necessary for establishing the correct
structure at telomeres.
It appears that not all of the telomere-related functions of the
SLX4 complex require stable association with telomeres,
because telomeres are longer and more fragile in organs and
cells from Slx4/ mice and telomere lengthening in Slx4/
MEFs can be reversed by expression of wild-type SLX4 (Figures
4B and 4C). From this perspective, SLX4 might mediate ‘‘telo-
mere trimming,’’ a mechanism that has been proposed to pre-
vent overlengthening of telomeres (Pickett and Reddel, 2012).
It is not yet clear which of the SLX4-associated nucleases are
required to prevent telomere lengthening. It is unlikely that
XPF-ERCC1 is the relevant nuclease because telomere length
is not affected in Ercc1/ mice (Zhu et al., 2003). The nuclease
that promotes SLX4-dependent telomere shortening could be
MUS81-EME1 and/or SLX1; it will be interesting to test the rele-
vant knockout mice for abnormally long telomeres. SLX1 is a
good candidate considering the Boulton lab has shown that it
is required for the production of T circles in cells lacking RTEL1
(Vannier et al., 2012). The consequences of overlong telomeres
for cell function and organism function are not clear, but this
will be interesting to study.EXPERIMENTAL PROCEDURES
Immunofluorescence Analysis
U2OS cells expressing GFP-SLX4 were preextracted in CSK buffer: 10 mM
PIPES (pH 6.8) containing 100 mM NaCl, 300 mM sucrose, 3 mM magnesium
chloride, 1 mM EGTA, and 0.5% [v/v] Triton X-100, fixed with 2% paraformal-
dehyde (PFA) (pH 7.0), permeabilized with PBS containing 0.5% (v/v) Triton X-
100, blocked with BSA (3% w/v) in PBS, and probed with primary antibodies
for 1 hr at room temperature. After extensive washing, cells were incubated
with secondary Alexa antibodies for 2 hr at room temperature. Cells weres
stained with DAPI before mounting on glass slides. Wide-field image stacks of
cells were acquired using a Deltavision microscope (Applied Precision) and
subjected to iterative deconvolution to remove out-of-focus light and were
further processed in OMERO (Allan et al., 2012). For endogenous SLX4 immu-
nofluorescence, cells grown on poly-L-lysine-coated coverslips were preex-
tracted in CSK buffer or PBS containing 0.5% Triton X-100 prior to fixation
in 3% PFA in CSK (pH 7.0). Cells were permeabilized in PBS-containing
0.5% (v/v) Triton X-100 and then blocked in antibody dilution buffer (AbDil):
PBS containing 5% normal donkey serum, 0.1% fish skin gelatin, 0.1% Triton
X-100, 0.05% Tween-20, and 0.05% sodium azide, before incubation with
primary antibodies in AbDil for 1 hr at room temperature or overnight at
4C. After washing, cells were incubated with the relevant secondary anti-
bodies for 2 hr at room temperature, stained with DAPI, and mounted on glass
slides.
Chromatin Immunoprecipitation
Cells grown to subconfluency on 15 cm plates were crosslinked with 1% (v/v)
formaldehyde for 15 min, with 0.125 M glycine for 5 min, and then washed
twice with PBS. Cells (4 3 106 cells per IP) were lysed in chromatin immuno-
precipitation (ChIP) lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl
[pH 8.0] plus protease inhibitors), followed by sonication for 15 s at 50%
amplitude and 30 s rest; this was repeated eight times at 4C before cells
were centrifuged at 12,000 rpm at 4C for 10 min. Cell supernatants were
diluted 1:10 in ChIP dilution buffer (1% [v/v] Triton X-100, 2 mM EDTA,
150 mM NaCl, and 20 mM Tris-HCl [pH 8.0]) and precleared with 2 mg of
sheared salmon sperm DNA (Invitrogen) and 20 ml protein G-Sepharose beads
per equivalent IP volume (2 ml). The supernatant was incubated with the rele-
vant antibodies overnight, before the addition of protein G-Sepharose beads
for 1 hr. After extensive washes, immune complexes were eluted with elution
buffer (100 mM NaHCO3 and 1% SDS) and incubated overnight at 65
C to
reverse crosslinks. Protein and RNA were removed by incubation with protein-
ase K and RNase A at 37C for 1 hr. DNA was purified by extraction with
phenol/chloroform/isoamyl alcohol (25:24:1), followed by centrifugation and
retrieval of the aqueous supernatant. DNA was precipitated with ice-cold
ethanol (96% v/v), washed with 70% ethanol, and resuspended in 100 ml of
water. Dot blotting and hybridization of ChIP are described in the Supple-
mental Information.
Full details of all other experimental procedures are given in the Extended
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
four figures and can be found with this article online at http://dx.doi.org/10.
1016/j.celrep.2013.07.033.
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